Based on the provided context, there is no direct evidence addressing the utility of CYP1A2 for sleep. None of the documents mention CYP1A2 or its relationship to sleep. In general scientific knowledge, CYP1A2 is the primary enzyme metabolizing caffeine. Variants (e.g., rs762551) influence caffeine clearance: slow metabolizers may experience prolonged caffeine effects, potentially disrupting sleep if caffeine is consumed later in the day. However, this is an indirect, lifestyle-related effect rather than a direct sleep disorder gene. Consumer DNA tests can indicate your metabolizer status, but the evidence for using CYP1A2 genotyping to improve sleep is weak and not supported by the given context. Clinical sleep assessments (e.g., polysomnography, sleep diaries) remain the gold standard. Caveat: Do not rely on a single SNP for sleep management; consider overall caffeine intake, timing, and other factors.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-ab59fa12fd0e94cf10aa3586